Blog

Installed Building Products Reports Record First Quarter 2022 Results and Declares Regular Quarterly Cash Dividend

COLUMBUS, Ohio--(BUSINESS WIRE)--Installed Building Products, Inc. (the "Company" or "IBP") (NYSE: IBP), an industry-leading installer of insulation and complementary building products, today announced results for the first quarter ended March 31, 2022. First Quarter 2022 Highlights (Comparisons are to Prior Year Period) Net revenue increased 34.4% to a quarterly record…
Leer más...

Emerald Holding, Inc. to Participate in the Goldman Sachs Seventh Annual Leveraged Finance and Credit Conference

NEW YORK--(BUSINESS WIRE)--Emerald Holding, Inc. (NYSE: EEX) (“Emerald” or the “Company”), today announced that Hervé Sedky, President and Chief Executive Officer, and David Doft, Chief Financial Officer, are scheduled to participate in the Goldman Sachs Seventh Annual Leveraged Finance and Credit Conference being held at the Terranea Resort in Rancho…
Leer más...

Leading Proxy Advisory Firm ISS Recommends Athira Shareholders “Withhold” Support From Incumbent Directors Joseph Edelman and John Fluke

ISS Would Have Recommended Shareholders “WITHHOLD” For Full Board Due to Classified Board Structure, Calls Board’s Mechanisms for Management Oversight to be “Lacking”, and Highlights Numerous Other Corporate Governance Missteps Ric Kayne Urges All Athira Shareholders to VOTE “FOR” Ric Kayne, George Bickerstaff, and Grant Pickering on the BLUE Proxy…
Leer más...

Marinus Pharmaceuticals Announces Resumption of Phase 3 RAISE Trial in Status Epilepticus

RADNOR, Pa.--(BUSINESS WIRE)--$MRNS #MarinusPharma--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it has resumed screening and recruitment for the Phase 3 RAISE (Randomized Therapy in Status Epilepticus) trial in refractory status epilepticus (RSE). The company continues…
Leer más...

BrightSphere Reports Financial and Operating Results for the First Quarter Ended March 31, 2022

BOSTON--(BUSINESS WIRE)--BrightSphere Investment Group Inc. (NYSE: BSIG) today announced its results for the first quarter ended March 31, 2022. BrightSphere’s earnings presentation is available at: https://ir.bsig.com The Company will hold a conference call and simultaneous webcast to discuss the results at 11:00 a.m. Eastern Time today. To listen to the…
Leer más...

Shift4 Announces First Quarter 2022 Results

ALLENTOWN, Pa.--(BUSINESS WIRE)--$FOUR--Shift4 (NYSE: FOUR), the leader in integrated payments and commerce technology, has posted its first quarter 2022 financial results as part of its 1Q 2022 Shareholder Letter under the Financials section of its Investor Relations website which can be found at https://investors.shift4.com. The Company’s Shareholder Letter can also…
Leer más...

FARXIGA met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascular death or worsening heart failure in patients with preserved ejection fraction

Results from the DELIVER and DAPA-HF Phase III trials demonstrate FARXIGA’s efficacy in heart failure regardless of ejection fraction WILMINGTON, Del.--(BUSINESS WIRE)--High-level results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) reached a statistically significant and clinically meaningful reduction in the primary composite endpoint of cardiovascular (CV) death…
Leer más...

Virios Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on Thursday, May 12, 2022

ATLANTA--(BUSINESS WIRE)--$VIRI #Biotech--Virios Therapeutics, Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia, announced today that its first quarter 2022 financial results will be reported on Thursday, May 12, 2022 before the open of the financial markets. Management…
Leer más...

Women’s Entrepreneurship Accelerator Publication Establishes the Business Case for Gender-Responsive Procurement

Evidence-based Advocacy Brief calls on the private sector to adopt gender-responsive procurement strategies and integrate women-owned, led and gender-responsive businesses into value chains as a vehicle for advancing businesses’ economic goals and social value in line with the Sustainable Development Goals. NEW YORK--(BUSINESS WIRE)--The Women’s Entrepreneurship Accelerator (WEA) today announced…
Leer más...